DocketNumber: No. 16533-99S
Judges: "Marvel, L. Paige"
Filed Date: 7/23/2001
Status: Non-Precedential
Modified Date: 4/18/2021
*210 PURSUANT TO INTERNAL REVENUE CODE SECTION 7463(b), THIS OPINION MAY NOT BE TREATED AS PRECEDENT FOR ANY OTHER CASE.
MARVEL, JUDGE: This case was heard pursuant to the provisions of section 7463 in effect at the time the petition was filed.
INVESTMENT IN JOJOBA RESEARCH PARTNERS, HAWAII
In 1982, petitioner's accountant, Robert Mihara, introduced petitioner to an investment opportunity in a limited partnership known as Jojoba Research Partners, Hawaii (Jojoba). Jojoba had entered into agreements with U.S. Agri-Research and Development Corp. (Agri-Research) under which Agri-Research would provide agricultural research and development services with respect to the growing of jojoba plants. In connection with its activities, Jojoba planned to deduct research and development expenditures under
Petitioner believes, but is not certain, that he reviewed a private placement memorandum (PPM) and a tax opinion letter in connection with his proposed investment in Jojoba. *213 The PPM, dated October 28, 1982, stated: "THIS OFFERING INVOLVES A HIGH DEGREE OF RISK". The PPM also stated:
PROSPECTIVE INVESTORS ARE CAUTIONED NOT TO CONSTRUE THIS
MEMORANDUM OR ANY PRIOR OR SUBSEQUENT COMMUNICATIONS AS
CONSTITUTING LEGAL OR TAX ADVICE. * * * INVESTORS ARE URGED TO
CONSULT THEIR OWN COUNSEL AS TO ALL MATTERS CONCERNING THIS
INVESTMENT.
PRIOR TO THE SALE OF ANY UNITS, EACH PURCHASER AND/OR HIS
OFFEREE REPRESENTATIVE SHALL HAVE THE OPPORTUNITY TO ASK
QUESTIONS OF THE GENERAL PARTNER CONCERNING ANY ASPECT OF THE
INVESTMENT DESCRIBED HEREIN. EACH INVESTOR MAY OBTAIN ANY
ADDITIONAL INFORMATION NECESSARY TO VERIFY THE ACCURACY OF THE
INFORMATION CONTAINED IN THIS MEMORANDUM TO THE EXTENT THAT THE
GENERAL PARTNER POSSESSES SUCH INFORMATION OR CAN ACQUIRE IT
WITHOUT UNREASONABLE EFFORT OR EXPENSE.
* * * * * * *
NO REPRESENTATIONS OR WARRANTIES OF ANY KIND ARE INTENDED
OR SHOULD BE INFERRED WITH RESPECT TO THE ECONOMIC RETURN OR TAX
ADVANTAGES WHICH MAY*214 ACCRUE TO THE INVESTORS IN THE UNITS.
EACH PURCHASER OF UNITS HEREIN SHOULD AND IS EXPECTED TO
CONSULT WITH HIS OWN TAX ADVISOR AS TO THE TAX ASPECTS.
In addition to the general warnings, the PPM described the risk factors with respect to the projected Federal income tax consequences of an investment in Jojoba as follows:
The General Partner anticipates that a substantial portion
of the capital contributions of the Limited Partners to the
Partnership will be used for research and experimental
expenditures of the type generally covered by
Code. However, prospective investors should be aware that there
is little published authority dealing with the specific types of
expenditures which will qualify as research or experimental
expenditures within the meaning of
expenditures contemplated by the Partnership have not been the
subject of any prior cases or administrative determinations.
* * * * * * *
No ruling by the Service has been or will be sought regarding
*215 deductibility of the proposed expenditures under
the Code.
The PPM referred prospective investors to a November 8, 1992, tax opinion letter prepared by the law firm of Caplan & Resnick and addressed to Jojoba's general partner (Caplan letter). The Caplan letter discussed various Federal income tax principles and opined regarding the application of those principles to the Jojoba investment. Caplan & Resnick based its opinion on the representations made by Jojoba's general partner, which the firm claimed it independently verified by personally interviewing officers of Agri- Research, visiting a typical experimental jojoba plantation, and reviewing various documents, including the PPM, the research and development agreement, the license agreement, and documentation concerning the acquisition of rights to the use of real property upon which the research would be conducted. The Caplan letter specifically addressed the deductibility of research and development expenditures under
Because of the scarcity of judicial opinions and legislative
enactments regarding
*216 incur expenses which are not presently contemplated, it is not
possible to guarantee the deductibility of certain expenditures
as research and development expenses. The General Partner
intends to conduct the * * * [Jojoba] business such that, to the
extent possible, substantially all * * * [Jojoba's] expenditures
for research and development qualify under
Before making the investment in Jojoba, petitioner discussed with Mr. Mihara Jojoba's profit potential and the research and development deduction that Jojoba anticipated claiming. Although Mr. Mihara had no expertise regarding jojoba as a marketable commodity, research and development expenditures generally, or the requirements of
PETITIONERS' 1982 FEDERAL INCOME TAX RETURN
For the taxable year 1982, Jojoba allocated an ordinary loss of $ 12,971 to petitioner, as reflected in his 1982 Schedule K-1, Partner's Share of Income, Credits, Deductions, Etc., issued by Jojoba, which petitioners deducted on their 1982 joint Federal income tax return.
On October 18, 1993, the tax matters partner of Jojoba entered into a stipulation with respondent agreeing to be bound by this Court's decision in
On August 6, 1999, respondent issued a notice of deficiency to petitioners for 1982 in which he determined that petitioners are liable for an addition to tax for negligence pursuant to
DISCUSSION
The Commissioner's decision to impose the negligence penalty is presumptively correct.
At trial, *221 not need to independently investigate the investment because, as an investor of moderate means, he was entitled to rely upon the offering materials and the expertise of his accountant,
When an accountant or*222 attorney advises a taxpayer on a
matter of tax law, such as whether a liability exists, it is
reasonable for the taxpayer to rely on that advice. Most
taxpayers are not competent to discern error in the substantive
advice of an accountant or attorney. To require the taxpayer to
challenge the attorney, to seek a "second opinion," or to try to
monitor counsel on the provisions of the Code himself would
nullify the very purpose of seeking the advice of a presumed
expert in the first place. "Ordinary business care and prudence"
do not demand such actions. [Citation omitted.]
Respondent argued that petitioner was negligent and that petitioner did not have a reasonable basis for his reporting position regarding Jojoba. We agree that petitioner's reliance on the offering materials and on the advice of his accountant is not an adequate defense.
It is well settled that a taxpayer's reliance upon offering materials prepared in connection with the sale of an investment or upon the representations of investment insiders and promoters is not reasonable.
Petitioner's reliance on
We find that petitioner's failure to exercise reasonable care in determining whether to invest in Jojoba was negligent and that petitioner's reliance*226 on Mr. Mihara for advice regarding the Jojoba investment was not reasonable. Accordingly, we hold that petitioners are liable for the addition to tax for negligence under
To reflect the foregoing,
Decision will be entered under Rule 155.
1. All subsequent section references are to the Internal Revenue Code in effect for the year in issue, and all Rule references are to the Tax Court Rules of Practice and Procedure.↩
2. In his notice of deficiency, respondent determined that petitioners are liable for a negligence penalty in the amount of 50 percent of the interest due on $ 13,367. Respondent conceded in his trial memorandum that the penalty should be limited to 50 percent of the interest due on $ 6,479.↩
3. Petitioner conceded that, even if he did review the PPM before making his investment, he probably did not read the entire document.↩
4. Mr. Mihara had no personal knowledge regarding the jojoba plantation, but he did receive occasional progress letters from Agri- Research regarding the activities allegedly being conducted on the jojoba plantation. Petitioner may have seen some of these progress letters but, at the time of trial, he did not recall whether he received any specific letter.↩
5. The parties agreed not to submit posttrial briefs in this case. After the trial, petitioner presented a closing argument, and respondent submitted a memorandum of authorities with the consent of petitioner.↩
6. Petitioners also argued that we should abate the interest accrued on the 1982 deficiency. See sec. 6404(e). Petitioners, however, have not complied with the statutory requirements for abatement. Whether petitioners are entitled to abatement of interest is not properly before us. See id.↩
7. The PPM did not make any affirmative statements indicating that the research and development deduction would be allowed by the IRS and, in fact, warned against misconstruing the document as indicating the deduction would be proper. Likewise, the Caplan letter stated that the deduction might be subject to attack by the IRS and that "Several commentators have discussed the potential that the IRS may attack a research and development partnership on the basis that it constitutes a material distortion of income." The Caplan letter also pointed out the lack of judicial opinions and legislative enactments regarding
Allen v. Commissioner ( 1989 )
Freytag v. Commissioner ( 1991 )
John E. Hansen Imelda M. Hansen v. Commissioner of Internal ... ( 1987 )
David G. Collins Pamela Collins Bernie Gates Maureen Gates ... ( 1988 )
Kenneth Allen Barbara Allen v. Commissioner of Internal ... ( 1991 )
Bixby v. Commissioner ( 1972 )
David E. Heasley and Kathleen Heasley v. Commissioner of ... ( 1990 )
United States v. Boyle ( 1985 )
Carlos and Jacqueline Marcello v. Commissioner of Internal ... ( 1967 )
Zachary H. Sacks and Salley Sacks v. Commissioner of ... ( 1996 )
thomas-l-freytag-and-sharon-n-freytag-v-commissioner-of-internal ( 1990 )
Leo Goldman and Pauline Goldman v. Commissioner of Internal ... ( 1994 )
William R. And Lorna E. Hall v. Commissioner of Internal ... ( 1984 )
Freytag v. Commissioner ( 1987 )
George v. Zmuda and Walburga Zmuda v. Commissioner of ... ( 1984 )